Connection
Brian Day to Cystic Fibrosis
This is a "connection" page, showing publications Brian Day has written about Cystic Fibrosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.867 |
|
|
|
-
Dickerhof N, Huang J, Min E, Micha?lsson E, Lindstedt EL, Pearson JF, Kettle AJ, Day BJ. Myeloperoxidase inhibition decreases morbidity and oxidative stress in mice with cystic fibrosis-like lung inflammation. Free Radic Biol Med. 2020 05 20; 152:91-99.
Score: 0.360
-
Chandler JD, Min E, Huang J, McElroy CS, Dickerhof N, Mocatta T, Fletcher AA, Evans CM, Liang L, Patel M, Kettle AJ, Nichols DP, Day BJ. Antiinflammatory and Antimicrobial Effects of Thiocyanate in a Cystic Fibrosis Mouse Model. Am J Respir Cell Mol Biol. 2015 Aug; 53(2):193-205.
Score: 0.262
-
Day BJ. Glutathione: a radical treatment for cystic fibrosis lung disease? Chest. 2005 Jan; 127(1):12-4.
Score: 0.126
-
Day BJ, van Heeckeren AM, Min E, Velsor LW. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Infect Immun. 2004 Apr; 72(4):2045-51.
Score: 0.119